£0.33
£0.00 (0.00%)
End-of-day quote: 05/17/2024
AIM:EKF
EKF Diagnostics Holdings Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PG | Procter & Gamble | NYSE | Outperform | $167.64 | $166.80 | 0.00% | 5 | $395.65B |
| ABT | Abbott Laboratories | NYSE | Outperform | $104.09 | $118.92 | 0.00% | 7 | $181.08B |
| CHD | Church & Dwight Co Inc | NYSE | Hold | $106.39 | $96.90 | 0.00% | 15 | $26.01B |
| BIM | bioMérieux | ENXTPA | Outperform | 95.90€ | 105.55€ | 0.00% | 1 | 11.73€B |
| BIO | Bio-Rad Laboratories Inc | NYSE | Outperform | $293.85 | $536.80 | 0.00% | 1 | $7.92B |
| QDEL | Quidel Corp | NASDAQ | Hold | $42.82 | $121.00 | 0.00% | 6 | $2.92B |
| ALBIO | Biosynex | ENXTPA | - | 6.28€ | 0.00€ | 0.00% | 0 | 79.68€M |
| AT1 | Atomo Diagnostics | ASX | - | $0.03 | $0.11 | 0.00% | 0 | $19.82M |
